Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Cancerfonden (-)
- License Information
-
More Information
Article History
First Online: 30 September 2025
Competing interests
: G.C.-B. is a shareholder and board member at Nexus Epigenomics. The other authors declare no competing interests.
